Showing results (241-250 of 718) with videos related to
Sort By:
Pageof 72
Respiratory Medicine|October 13, 2014
Dysnatremia, vasopressin, atrial natriuretic peptide and mortality in patients with community-acquired pneumonia: results from the german competence network CAPNETZStefan Krüger, Santiago Ewig, Sven Giersdorf, et al.Plos One|March 16, 2016
Topical Nasal Anesthesia in Flexible Bronchoscopy--A Cross-Over Comparison between Two DevicesThomas Fuehner, Jan Fuge, Meike Jungen, et al.Clinical Transplantation|January 31, 2018
Self-reported non-adherence to immunosuppressive medication in adult lung transplant recipients-A single-center cross-sectional studyNora Drick, Benjamin Seeliger, Jan Fuge, et al.Sleep & Breathing = Schlaf & Atmung|March 19, 2002
Obstructive Sleep Apnea and Hypopnea Efficacy and Safety of a Long-Acting beta2-AgonistKurt Rasche, Hans-Werner Duchna, Julia Lauer, et al.Pulmonary Pharmacology & Therapeutics|February 26, 2008
Inflammatory responses after endothelin B (ETB) receptor activation in human monocytes: new evidence for beneficial anti-inflammatory potency of ETB-receptor antagonismUwe R Juergens, Kurt Racké, Sakir Uen, et al.Respiratory Research|July 15, 2009
Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP: results from the German competence network CAPNETZStefan Krüger, Santiago Ewig, Jana Papassotiriou, et al.Respiration; International Review of Thoracic Diseases|December 5, 2008
Expression, localisation and functional implications of the transporter protein PEPT2 in the upper respiratory tractDavid Quarcoo, Tanja C Fischer, Werner Heppt, et al.The Journal of Thoracic and Cardiovascular Surgery|July 29, 2006
Long-term outcome after pulmonary retransplantationMartin Strueber, Stefan Fischer, Jens Gottlieb, et al.Respiratory Medicine|December 6, 2017
Comparison of exercise training responses in COPD patients with and without Alpha-1 antitrypsin deficiencyInga Jarosch, Wolfgang Hitzl, Andreas Rembert Koczulla, et al.International Journal of Chronic Obstructive Pulmonary Disease|March 31, 2017
Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular functionBenjamin Waschki, Henrik Watz, Olaf Holz, et al.Pageof 72